{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:29:54Z","timestamp":1793345394042,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS\\u20102023\\u201000301974"],"award-info":[{"award-number":["RS\\u20102023\\u201000301974"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-25439144"],"award-info":[{"award-number":["RS-2025-25439144"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022M3A9G1014520"],"award-info":[{"award-number":["NRF-2022M3A9G1014520"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2023R1A2C2003034"],"award-info":[{"award-number":["2023R1A2C2003034"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025\\u201300516213"],"award-info":[{"award-number":["RS-2025\\u201300516213"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bcp.2025.117607","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:04:34Z","timestamp":1764979474000},"page":"117607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Discovery of a novel selective small molecule interleukin-36 receptor antagonist for inflammation and cancer"],"prefix":"10.1016","volume":"245","author":[{"given":"Abdul Waheed","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Haseeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuk-Kwon","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6814-122X","authenticated-orcid":false,"given":"Sangdun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117607_b0005","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3389\/fimmu.2019.02532","article-title":"Biology of IL-36 signaling and its role in systemic inflammatory diseases","volume":"10","author":"Yuan","year":"2019","journal-title":"Front. Immunol."},{"issue":"420","key":"10.1016\/j.bcp.2025.117607_b0010","article-title":"An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target","volume":"9","author":"Mahil","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117607_b0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-kappaB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2025.117607_b0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-kappaB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2025.117607_b0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00432-023-05572-7","article-title":"Natural products targeting the MAPK-signaling pathway in cancer: overview","volume":"150","author":"Shi","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bcp.2025.117607_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155897","article-title":"Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions","volume":"156","author":"Sachen","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.bcp.2025.117607_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108762","article-title":"Interleukin-36beta exacerbates DSS-induce acute colitis via inhibiting Foxp3(+) regulatory T cell response and increasing Th2 cell response","volume":"108","author":"Zhu","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117607_b0040","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41385-022-00488-w","article-title":"IL-36 cytokines imprint a colitogenic phenotype on CD4(+) T helper cells","volume":"15","author":"Leon","year":"2022","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.bcp.2025.117607_b0045","doi-asserted-by":"crossref","first-page":"1604332","DOI":"10.3389\/fimmu.2025.1604332","article-title":"IL-36\/IL-36R signaling promotes CD4+ T cell-dependent colitis via pro-inflammatory cytokine production","volume":"16","author":"Maarouf","year":"2025","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117607_b0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cei.12761","article-title":"Distinct expression of interleukin (IL)-36alpha, beta and gamma, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease","volume":"184","author":"Boutet","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"491","key":"10.1016\/j.bcp.2025.117607_b0055","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan2585","article-title":"TGF-beta type 2 receptor-mediated modulation of the IL-36 family can be therapeutically targeted in osteoarthritis","volume":"11","author":"Li","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"19","key":"10.1016\/j.bcp.2025.117607_b0060","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/s41388-022-02281-2","article-title":"IL-36 signalling enhances a pro-tumorigenic phenotype in colon cancer cells with cancer cell growth restricted by administration of the IL-36R antagonist","volume":"41","author":"Baker","year":"2022","journal-title":"Oncogene"},{"issue":"15","key":"10.1016\/j.bcp.2025.117607_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153654","article-title":"Regulation of interleukin-36gamma\/IL-36R signaling Axis by PIN1 in epithelial cell transformation and breast tumorigenesis","volume":"14","author":"Poudel","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2025.117607_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156170","article-title":"IL-36 expression is increased in NSCLC with IL-36 stimulation of lung cancer cells promoting a pro-tumorigenic phenotype","volume":"165","author":"Baker","year":"2023","journal-title":"Cytokine"},{"issue":"19","key":"10.1016\/j.bcp.2025.117607_b0075","article-title":"IL-36gamma and IL-36Ra reciprocally regulate NSCLC progression by modulating GSH homeostasis and oxidative stress-induced cell death","volume":"8","author":"Wang","year":"2021","journal-title":"Adv. Sci. (weinh)"},{"key":"10.1016\/j.bcp.2025.117607_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155887","article-title":"IL-36G promotes cancer-cell intrinsic hallmarks in human gastric cancer cells","volume":"155","author":"Le","year":"2022","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.bcp.2025.117607_b0085","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41416-022-02083-z","article-title":"Transcriptomic and functional analyses reveal a tumour-promoting role for the IL-36 receptor in colon cancer and crosstalk between IL-36 signalling and the IL-17\/ IL-23 axis","volume":"128","author":"Baker","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.bcp.2025.117607_b0090","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","article-title":"NF-kappaB, an active player in human cancers","volume":"2","author":"Xia","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"16","key":"10.1016\/j.bcp.2025.117607_b0095","doi-asserted-by":"crossref","first-page":"11153","DOI":"10.1074\/jbc.M113.540237","article-title":"The mitogen-activated protein (MAP) kinases p38 and extracellular signal-regulated kinase (ERK) are involved in hepatocyte-mediated phenotypic switching in prostate cancer cells","volume":"289","author":"Ma","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2025.117607_b0100","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/ci3001277","article-title":"ZINC: a free tool to discover chemistry for biology","volume":"52","author":"Irwin","year":"2012","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"10.1016\/j.bcp.2025.117607_b0105","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1021\/acs.jcim.2c01253","article-title":"ZINC-22 horizontal line a free multi-billion-scale database of tangible compounds for ligand discovery","volume":"63","author":"Tingle","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bcp.2025.117607_b0110","unstructured":"MOE Molecular Operating Environment (MOE), 2022.02 Chemical Computing Group ULC, 910-1010 Sherbrooke St. W., Montreal, QC H3A 2R7, Canada, 2023., 2022.02., (2022)."},{"issue":"13","key":"10.1016\/j.bcp.2025.117607_b0115","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1021\/acs.jcim.4c00578","article-title":"Discovery of novel small molecule dual inhibitor targeting toll-like receptors 7 and 9","volume":"64","author":"Haseeb","year":"2024","journal-title":"J. Chem. Inf. Model."},{"issue":"6","key":"10.1016\/j.bcp.2025.117607_b0120","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1021\/acschemneuro.1c00831","article-title":"Novel small-molecule inhibitor of NLRP3 inflammasome reverses cognitive impairment in an alzheimer's disease model","volume":"13","author":"Haseeb","year":"2022","journal-title":"ACS Chem. Neurosci."},{"issue":"7","key":"10.1016\/j.bcp.2025.117607_b0125","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/pro.3862","article-title":"X-ray crystal structure localizes the mechanism of inhibition of an IL-36R antagonist monoclonal antibody to interaction with Ig1 and Ig2 extra cellular domains","volume":"29","author":"Larson","year":"2020","journal-title":"Protein Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117607_b0130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117607_b0135","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1038\/s41598-019-45626-w","article-title":"Small Molecule IL-36gamma antagonist as a novel therapeutic approach for plaque psoriasis","volume":"9","author":"Todorovic","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2025.117607_b0140","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123390","article-title":"Disrupting the IL-36 and IL-23\/IL-17 loop underlies the efficacy of calcipotriol and corticosteroid therapy for psoriasis","volume":"4","author":"German","year":"2019","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.bcp.2025.117607_b0145","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/2211-5463.12406","article-title":"Identification of small-molecule elastase inhibitors as antagonists of IL-36 cytokine activation","volume":"8","author":"Sullivan","year":"2018","journal-title":"FEBS Open Bio"},{"issue":"49","key":"10.1016\/j.bcp.2025.117607_b0150","doi-asserted-by":"crossref","first-page":"42594","DOI":"10.1074\/jbc.M111.267922","article-title":"Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36alpha, IL-36beta, and IL-36gamma) or antagonist (IL-36Ra) activity","volume":"286","author":"Towne","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117607_b0155","unstructured":"ZINC20. http:\/\/zinc20.docking.org\/patterns\/home\/."},{"key":"10.1016\/j.bcp.2025.117607_b0160","unstructured":"GROMACS."},{"issue":"1","key":"10.1016\/j.bcp.2025.117607_b0165","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field","volume":"12","author":"Lee","year":"2016","journal-title":"J. Chem. Theory Comput."},{"issue":"20","key":"10.1016\/j.bcp.2025.117607_b0170","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1016\/j.bmc.2016.06.034","article-title":"Parametrization of halogen bonds in the CHARMM general force field: improved treatment of ligand-protein interactions","volume":"24","author":"Soteras Gutierrez","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2025.117607_b0175","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Valdes-Tresanco","year":"2021","journal-title":"J. Chem. Theory Comput."},{"issue":"9","key":"10.1016\/j.bcp.2025.117607_b0180","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bcp.2025.117607_b0185","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald","volume":"98","author":"Pedersen","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"12","key":"10.1016\/j.bcp.2025.117607_b0190","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bcp.2025.117607_b0195","article-title":"The PyMOL molecular graphics system","author":"Schrodinger","year":"2021","journal-title":"(no Title)"},{"key":"10.1016\/j.bcp.2025.117607_b0200","unstructured":"P. Turner, XMGRACE, Version 5.1. 19, Center for coastal and land-margin research, Oregon Graduate Institute of Science and Technology, Beaverton, OR 2(5) (2005) 19."},{"issue":"14","key":"10.1016\/j.bcp.2025.117607_b0205","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1074\/jbc.275.14.10308","article-title":"Identification and initial characterization of four novel members of the interleukin-1 family","volume":"275","author":"Kumar","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117607_b0210","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3389\/fimmu.2019.01162","article-title":"Interleukin-36 in Infectious and Inflammatory Skin Diseases","volume":"10","author":"Buhl","year":"2019","journal-title":"Front. Immunol."},{"issue":"411","key":"10.1016\/j.bcp.2025.117607_b0215","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan2514","article-title":"An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target","volume":"9","author":"Mahil","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.bcp.2025.117607_b0220","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/jdv.19935","article-title":"The role of interleukin-36 in health and disease states","volume":"38","author":"Sugiura","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117607_b0225","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/s41467-025-56601-7","article-title":"Discovery of selective low molecular weight interleukin-36 receptor antagonists by encoded library technologies","volume":"16","author":"Velcicky","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117607_b0230","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2147\/CMAR.S407123","article-title":"The pro-tumor biological function of IL-36alpha plays an important role in the tumor microenvironment of HCC","volume":"15","author":"Song","year":"2023","journal-title":"Cancer Manag. Res."},{"issue":"23","key":"10.1016\/j.bcp.2025.117607_b0235","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.21037\/atm-21-5991","article-title":"IL-36beta promotes anti-tumor effects in CD8(+) T cells by downregulating micro-RNA let-7c-5p","volume":"9","author":"Li","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.bcp.2025.117607_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111096","article-title":"IL-36 antagonism blunts the proliferation and migration of oral squamous cell carcinoma cells","volume":"117","author":"Li","year":"2024","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.bcp.2025.117607_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084365","article-title":"The clinical significance and involvement in molecular cancer processes of chemokine CXCL1 in selected tumors","volume":"25","author":"Korbecki","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117607_b0250","doi-asserted-by":"crossref","DOI":"10.1093\/immadv\/ltad011","article-title":"Blockade of innate inflammatory cytokines TNFalpha, IL-1beta, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regression","volume":"3","author":"Walsh","year":"2023","journal-title":"Immunother Adv."},{"issue":"31","key":"10.1016\/j.bcp.2025.117607_b0255","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1038\/onc.2010.182","article-title":"Metabolism and proliferation share common regulatory pathways in cancer cells","volume":"29","author":"Fritz","year":"2010","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bcp.2025.117607_b0260","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1002\/mco2.218","article-title":"Metabolic reprogramming in cancer: mechanisms and therapeutics","volume":"4","author":"Nong","year":"2023","journal-title":"MedComm"},{"issue":"19","key":"10.1016\/j.bcp.2025.117607_b0265","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101501","article-title":"IL\u201036\u03b3 and IL\u201036Ra reciprocally regulate nsclc progression by modulating gsh homeostasis and oxidative stress\u2010induced cell death","volume":"8","author":"Wang","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bcp.2025.117607_b0270","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pharmthera.2017.10.018","article-title":"Emerging tumor spheroids technologies for 3D in vitro cancer modeling","volume":"184","author":"Rodrigues","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2025.117607_b0275","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.4143\/crt.2015.189","article-title":"Overexpression of endoplasmic reticulum oxidoreductin 1-alpha (ERO1L) is associated with poor prognosis of gastric cancer","volume":"48","author":"Seol","year":"2016","journal-title":"Cancer Res. Treat."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500872X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500872X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:24:30Z","timestamp":1781699070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522500872X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":55,"alternative-id":["S000629522500872X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117607","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a novel selective small molecule interleukin-36 receptor antagonist for inflammation and cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117607","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117607"}}